Clindamycin is generally considered safe during pregnancy and is one of the antibiotics most commonly prescribed to pregnant women. It carries a former FDA Pregnancy Category B rating, meaning animal studies showed no harm and limited human data supports its safety. That said, the form you take (topical, vaginal, or oral) and your stage of pregnancy both matter when weighing the risks.
How the Form of Clindamycin Affects Risk
Not all clindamycin is absorbed equally, and the amount that reaches your bloodstream directly determines how much your baby is exposed to. Topical clindamycin, the kind applied to skin for acne, allows only tiny amounts to pass through and enter your circulation. Because oral and vaginal forms have higher absorption and still haven’t been linked to increased birth defects, topical use is considered the lowest-risk option by a wide margin.
Vaginal clindamycin cream falls in the middle. It’s absorbed more than a skin cream but less than a pill, which is why clinical guidelines from the American College of Obstetricians and Gynecologists specifically recommend vaginal cream over oral therapy in the first trimester for conditions like bacterial vaginosis. The standard regimen is one full applicator of 2% cream at bedtime for seven days.
Oral clindamycin has the highest absorption. When taken by mouth, the drug does cross the placenta efficiently. A study of 23 women receiving intravenous clindamycin found that 96% of cord blood samples reached the same therapeutic levels as the mother’s blood, with an average cord blood concentration of 3.35 micrograms per milliliter compared to 4.46 in maternal blood. This doesn’t mean oral use is dangerous, but it does mean the baby gets a meaningful dose of the medication.
Safety by Trimester
The second and third trimesters have the most reassuring data. Clinical trials of women who took clindamycin systemically during these trimesters found no increased frequency of birth defects. A 2025 review in Pharmacotherapy summarized that no clinical studies have reported findings of increased risk for major birth defects or miscarriage, and classified clindamycin as generally safe in pregnancy.
The first trimester is where the picture gets more complicated. There are no well-controlled studies of systemic clindamycin use during the first 12 weeks, which is the critical window for organ development. One large population-based cohort study published in the British Journal of Clinical Pharmacology did flag a potential signal: among 380 pregnancies with clindamycin exposure, researchers found a 34% increased risk of major birth defects after adjusting for other factors. The specific concerns were a 67% increased risk of musculoskeletal malformations and an 81% increased risk of heart septal defects (small holes between heart chambers). However, the absolute numbers were small (60 total cases of birth defects out of 380 exposures), and observational studies like this can’t prove the drug caused the problem. Other factors, including the infection being treated, could explain some of the association.
Because of this uncertainty, prescribing guidelines recommend using clindamycin in the first trimester “only if clearly needed,” and favoring the vaginal cream form over pills when possible to limit how much reaches the baby.
Common Reasons It’s Prescribed in Pregnancy
Bacterial vaginosis is the most frequent reason pregnant women receive clindamycin. BV during pregnancy is linked to preterm delivery, and treating it may reduce that risk in high-risk patients. Clindamycin is also prescribed for dental infections, skin and soft tissue infections, and as an alternative for women allergic to penicillin.
For acne, topical clindamycin is one of the few options considered acceptable during pregnancy, since many other acne treatments (like retinoids and certain oral antibiotics) are clearly unsafe. The minimal skin absorption makes it a practical choice when pregnancy-related breakouts need treatment.
Side Effects to Watch For
Clindamycin is notably harder on the digestive system than most antibiotics, and pregnancy already makes GI symptoms worse for many women. In one study, 98% of patients taking oral clindamycin experienced some side effects. Diarrhea is the most common, lasting an average of three days at a 300 mg dose and five days at 600 mg. Stomach pain and cramping are also frequent.
The more serious concern is a bacterial infection called C. difficile colitis, which clindamycin triggers at higher rates than other antibiotics. This causes severe, persistent diarrhea and colon inflammation. Even a single dose can potentially set it off. If you develop watery diarrhea that doesn’t improve or contains blood, that needs prompt medical attention regardless of whether you’re pregnant.
Vaginal and topical forms cause far fewer GI problems because so much less of the drug enters your system.
Clindamycin While Breastfeeding
Small amounts of clindamycin do pass into breast milk. After a 150 mg oral dose, milk levels averaged about 1.2 mg per liter. This is a low concentration, but because clindamycin can disrupt gut bacteria, there’s a theoretical risk of causing diarrhea or yeast infections (thrush, diaper rash) in a nursing baby. These effects are uncommon enough that breastfeeding doesn’t need to stop during clindamycin treatment, but watching for loose stools or white patches in the baby’s mouth is reasonable.
Topical clindamycin for acne is unlikely to produce enough drug in breast milk to affect an infant at all, with one exception: if applied directly to the breast area, the baby could ingest it during nursing.